Enzo Biochem (ENZ) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChart

Enzo Biochem Revenue Highlights


Latest Revenue (Y)

$31.91M

Latest Revenue (Q)

$6.21M

Main Segment (Y)

Consolidated Member

Main Geography (Y)

UNITED STATES

Enzo Biochem Revenue by Period


Enzo Biochem Revenue by Year

DateRevenueChange
2024-07-31$31.91M2.72%
2023-07-31$31.06M-70.99%
2022-07-31$107.07M-9.05%
2021-07-31$117.73M54.87%
2020-07-31$76.02M-6.34%
2019-07-31$81.17M-22.48%
2018-07-31$104.71M-2.87%
2017-07-31$107.80M4.90%
2016-07-31$102.77M5.30%
2015-07-31$97.60M1.72%
2014-07-31$95.95M2.39%
2013-07-31$93.71M-9.10%
2012-07-31$103.08M1.03%
2011-07-31$102.03M5.10%
2010-07-31$97.08M8.38%
2009-07-31$89.57M15.14%
2008-07-31$77.80M47.04%
2007-07-31$52.91M32.85%
2006-07-31$39.83M-8.24%
2005-07-31$43.40M4.22%
2004-07-31$41.64M-21.08%
2003-07-31$52.77M-2.31%
2002-07-31$54.02M-7.52%
2001-07-31$58.41M16.75%
2000-07-31$50.03M12.93%
1999-07-31$44.30M9.65%
1998-07-31$40.40M15.76%
1997-07-31$34.90M1.16%
1996-07-31$34.50M8.83%
1995-07-31$31.70M39.04%
1994-07-31$22.80M14.00%
1993-07-31$20.00M-

Enzo Biochem generated $31.91M in revenue during NA 2024, up 2.72% compared to the previous quarter, and up 39.31% compared to the same period a year ago.

Enzo Biochem Revenue by Quarter

DateRevenueChange
2024-10-31$6.21M-17.45%
2024-07-31$7.53M-6.18%
2024-04-30$8.02M-6.21%
2024-01-31$8.55M9.57%
2023-10-31$7.81M-139.70%
2023-07-31$-19.66M-222.06%
2023-04-30$16.11M-1.41%
2023-01-31$16.34M-10.60%
2022-10-31$18.28M-9.90%
2022-07-31$20.28M-22.65%
2022-04-30$26.22M-22.98%
2022-01-31$34.05M28.38%
2021-10-31$26.52M6.88%
2021-07-31$24.81M-24.34%
2021-04-30$32.80M4.23%
2021-01-31$31.47M9.81%
2020-10-31$28.66M46.75%
2020-07-31$19.53M15.52%
2020-04-30$16.90M-12.80%
2020-01-31$19.38M-4.07%
2019-10-31$20.21M-3.41%
2019-07-31$20.92M6.40%
2019-04-30$19.66M1.73%
2019-01-31$19.33M-9.09%
2018-10-31$21.26M-13.06%
2018-07-31$24.45M-4.58%
2018-04-30$25.63M-4.91%
2018-01-31$26.95M-2.62%
2017-10-31$27.68M-1.76%
2017-07-31$28.17M4.00%
2017-04-30$27.09M3.16%
2017-01-31$26.26M-0.09%
2016-10-31$26.28M-1.20%
2016-07-31$26.60M0.64%
2016-04-30$26.43M7.63%
2016-01-31$24.56M-2.45%
2015-10-31$25.18M-2.02%
2015-07-31$25.70M7.13%
2015-04-30$23.99M3.87%
2015-01-31$23.09M-6.98%
2014-10-31$24.82M-0.33%
2014-07-31$24.91M3.87%
2014-04-30$23.98M4.58%
2014-01-31$22.93M-5.00%
2013-10-31$24.13M3.71%
2013-07-31$23.27M2.97%
2013-04-30$22.60M1.75%
2013-01-31$22.21M-13.34%
2012-10-31$25.63M-2.95%
2012-07-31$26.41M1.78%
2012-04-30$25.95M3.91%
2012-01-31$24.97M-3.03%
2011-10-31$25.75M-3.96%
2011-07-31$26.82M3.83%
2011-04-30$25.83M8.82%
2011-01-31$23.73M-7.48%
2010-10-31$25.65M2.83%
2010-07-31$24.95M4.86%
2010-04-30$23.79M2.60%
2010-01-31$23.19M-7.86%
2009-10-31$25.16M2.58%
2009-07-31$24.53M6.37%
2009-04-30$23.06M10.26%
2009-01-31$20.92M-0.70%
2008-10-31$21.06M-0.53%
2008-07-31$21.18M11.75%
2008-04-30$18.95M3.97%
2008-01-31$18.23M-

Enzo Biochem generated $6.21M in revenue during Q1 2025, up -17.45% compared to the previous quarter, and up -31.60% compared to the same period a year ago.

Enzo Biochem Revenue Breakdown


Enzo Biochem Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJul 22Jul 21Jul 20Jul 19Jul 18
Consolidated Member$107.07M----
LifeSciencesProductsMember-$30.75M---
ClinicalLaboratoryServicesMember-$86.98M---
ConsolidatedMember-$117.73M---
ClinicalServicesMember--$24.89M--
ClinicalServicesThreeMember--$5.98M--
ClinicalServices1Member--$10.82M--
ClinicalServicesTwoMember--$6.26M--
Clinical Labs---$51.12M-
Consolidated---$81.17M$104.71M
Life Sciences---$30.05M$29.94M

Enzo Biochem's latest annual revenue breakdown by segment (product or service), as of Jul 22: Consolidated Member (100.00%).

Quarterly Revenue by Product

Product/ServiceJul 22Apr 22Jan 22Oct 21Jul 21Apr 21Jan 21Oct 20Apr 20Jan 20Oct 19Jul 19Apr 19Jan 19Oct 18Jul 18Apr 18
Consolidated Member$20.28M----------------
ClinicalServicesMember-$18.63M$23.67M$16.75M$21.22M$9.74M-----------
ProductsMember-$7.59M$10.37M$6.78M$7.78M$7.48M-----------
ConsolidatedMember-$26.22M$34.05M$26.52M$32.80M$31.47M-----------
ClinicalLabsMember---$19.74M$25.02M$23.99M-----------
ClinicalServices1Member-------$3.26M$9.74M--------
ClinicalServicesThreeMember-------$1.87M$1.13M--------
ClinicalServicesTwoMember-------$2.56M$1.66M--------
Product Revenue---------$6.87M$7.43M------
Life Sciences-----------$7.85M$7.68M$7.49M---
Consolidated-----------$20.92M$19.66M$19.33M$21.26M$24.45M$25.63M
Clinical Services------------$11.75M$12.00M$14.30M--
Products------------$7.91M$7.33M$6.96M--
Clinical Labs---------------$16.78M$18.14M

Enzo Biochem's latest quarterly revenue breakdown by segment (product or service), as of Jul 22: Consolidated Member (100.00%).

Enzo Biochem Revenue Breakdown by Country

Annual Revenue by Country

CountryJul 24Jul 23Jul 22Jul 21Jul 20
Asia Pacific$3.86M$4.06M$4.29M$4.74M-
Europe$8.56M$8.45M$8.57M$10.39M-
UNITED STATES$19.49M$18.55M$19.78M$102.60M-
Consolidated Member--$107.07M--
RestofworldMember----$4.50M
European Union----$7.48M

Enzo Biochem's latest annual revenue breakdown by geography, as of Jul 24: UNITED STATES (61.08%), Europe (26.83%), and Asia Pacific (12.09%).

Quarterly Revenue by Country

CountryOct 24Jul 24Apr 24Jan 24Oct 23Jul 23Apr 23Jan 23Oct 22Jul 22Jan 22Oct 21Jul 21Apr 21Jan 21Oct 20Apr 20
UNITED STATES$3.76M$4.89M$4.79M$5.17M$4.63M$5.27M$5.04M$4.14M$4.09M$6.75K$3.86K$3.46M-----
Asia Pacific$785.00K$854.00K$870.00K$1.10M$1.03M$1.11M$754.00K$1.09M$1.10M$1.22K$908.00$1.11M$1.32M----
Europe$1.66M$1.78M$2.36M$2.29M$2.14M$2.58M$1.69M$2.28M$1.90M--------
Consolidated Member---------$20.28M-------
European Union----------$2.40K$2.01K$2.59M$2.73M$2.63M$2.38M$1.79M
RestofworldMember---------------$1.17M$1.17M

Enzo Biochem's latest quarterly revenue breakdown by geography, as of Oct 24: UNITED STATES (60.58%), Europe (26.78%), and Asia Pacific (12.63%).

Enzo Biochem Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
FONRFONAR$102.88B$25.94M
SHCSotera Health Company$1.05B$285.47M
BNRBurning Rock Biotech$537.43M$125.62M
CSTLCastle Biosciences$219.79M$85.78M
STIMNeuronetics$71.35M$16.45M
XGNExagen$52.55M$15.06M
BDSXBiodesix$49.09M$18.15M
ENZEnzo Biochem$31.91M$6.21M
PMDPsychemedics$22.10M$5.17M
DRIODarioHealth$20.35M$6.25M
SERASera Prognostics$306.00K$24.00K

ENZ Revenue FAQ


What is Enzo Biochem’s yearly revenue?

Enzo Biochem's yearly revenue for 2024 was $31.91M, representing an increase of 2.72% compared to 2023. The company's yearly revenue for 2023 was $31.06M, representing a decrease of -70.99% compared to 2022. ENZ's yearly revenue for 2022 was $107.07M, representing a decrease of -9.05% compared to 2021.

What is Enzo Biochem’s quarterly revenue?

Enzo Biochem's quarterly revenue for Q1 2025 was $6.21M, a -17.45% decrease from the previous quarter (Q4 2024), and a -20.41% decrease year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $7.53M, a -6.18% decrease from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). ENZ's quarterly revenue for Q3 2024 was $8.02M, a -6.21% decrease from the previous quarter (Q2 2024), and a -50.20% decrease year-over-year (Q3 2023).

What is Enzo Biochem’s revenue growth rate?

Enzo Biochem's revenue growth rate for the last 3 years (2022-2024) was -70.20%, and for the last 5 years (2020-2024) was -58.03%.

What are Enzo Biochem’s revenue streams?

Enzo Biochem's revenue streams in l 22 are Consolidated Member

What is Enzo Biochem’s main source of revenue?

For the fiscal year ending Jul 22, the largest source of revenue of Enzo Biochem was Consolidated Member. This segment made a revenue of $107.07M, representing 100.00% of the company's total revenue.